ResearcherOsaka City UniversityActive in the last 2 years
Yuko Kuwae
Matched on ORCID iD 0000-0002-4098-6359; OpenAlex author ID A5007154870, A5060545703. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17132212↗
- Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000220↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anna Kakehashi · 2 shared papers, 2015–2025 · strength 0.27
- Paper The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers17132212↗
- Paper Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000000220↗
- Hideki Wanibuchi · 2 shared papers, 2015–2025 · strength 0.27
- Paper The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers17132212↗
- Paper Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000000220↗
- Norifumi Kawada · 1 shared paper, 2025 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.